Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 17 results.
User Information
Export Records
  1. 1.   Analysis of the progression of cervical cancer in a low-and-middle-income country: From pre-malignancy to invasive disease
  2. Robinson, Emma; Rodriguez, Isabel; Argueta, Victor; Xie, Yi; Lou, Hong; Milano, Rose; Lee, Hyo Jung; Burdett, Laurie; Mishra,Sambit; Yeager,Meredith; Mirabello, Lisa; Dean, Michael; Orozco, Roberto
  3. Tumour Virus Research. 2024, Dec 11; 200299.
  1. 2.   A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening
  2. Vocke, Cathy D; Fleming, Leah R; Piskorski, Anna M; Amin, Ali; Phornphutkul, Chanika; de la Monte, Suzanne; Vilboux, Thierry; Duncan, Folami; Pellegrino, Joan; Braddock, Bonnie; Middelton, Lindsay A; Schmidt,Laura; Merino, Maria J; Cowen, Edward W; Introne, Wendy J; Linehan, W Marston; Smith, Ann C M
  3. American Journal of Medical Genetics. Part A. 2022, Dec 13;
  1. 3.   Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance
  2. O'Connor, Luke P; Wang, Alex Z; Yerram, Nitin K; Long, Lori; Ahdoot, Michael; Lebastchi, Amir H; Gurram, Sandeep; Zeng, Johnathan; Harmon,Stephanie; Mehralivand, Sherif; Merino, Maria J; Parnes, Howard L; Choyke, Peter L; Shih, Joanna H; Wood, Bradford J; Turkbey, Baris; Pinto, Peter A
  3. European Urology Oncology. 2021, Apr ; 4(2): 227-234.
  1. 4.   PIRADS Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance
  2. Wang, Alex Z; O'Connor, Luke P; Yerram, Nitin K; Long, Lori; Zeng, Johnathan; Mehralivand, Sherif; Harmon,Stephanie; Lebastchi, Amir H; Ahdoot, Michael; Gomella, Patrick T; Gurram, Sandeep; Choyke, Peter L; Merino, Maria J; Shih, Joanna H; Wood, Bradford J; Turkbey, Baris; Pinto, Peter A
  3. The Journal of urology. 2020, DEC; 204(6): 1229-1234.
  1. 5.   Combined MRI-targeted plus systematic confirmatory biopsy improves risk stratification for patients enrolling on active surveillance for prostate cancer
  2. O'Connor, Luke P; Wang, Alex Z; Yerram, Nitin K; Lebastchi, Amir H; Ahdoot, Michael; Gurram, Sandeep; Zeng, Johnathan; Mehralivand, Sherif; Harmon,Stephanie; Merino, Maria J; Parnes, Howard L; Choyke, Peter L; Turkbey, Baris; Wood, Bradford J; Pinto, Peter A
  3. Urology. 2020, OCT; 144: 164-170.
  1. 6.   AGO-bound mature miRNAs are oligouridylated by TUTs and subsequently degraded by DIS3L2
  2. Yang,Acong; Shao, Tie-Juan; Bofill De Ros,Xavier; Lian, Chuanjiang; Villanueva, Patricia; Dai,Lisheng; Gu,Shuo
  3. Nature communications. 2020, Jun 02; 11(1): 2765.
  1. 7.   NK cells prevent T cell lymphoma development in T cell receptor-transgenic mice
  2. Dubois, Sigrid; Feigenbaum, Lionel; Waldmann, Thomas A; Müller, Jürgen R
  3. Cellular immunology. 2020, JUN; 352: 104081.
  1. 8.   MRI of localized prostate cancer: coming of age in the PSA era
  2. Turkbey, B.; Bernardo, M.; Merino, M. J.; Wood, B. J.; Pinto, P. A.; Choyke, P. L.
  3. Diagnostic and Interventional Radiology. 2012, Jan-Feb; 18(1): 34-45.
  1. 9.   Is Apparent Diffusion Coefficient Associated with Clinical Risk Scores for Prostate Cancers that Are Visible on 3-T MR Images ?
  2. Turkbey, B.; Shah, V. P.; Pang, Y. X.; Bernardo, M.; Xu, S.; Kruecker, J.; Locklin, J.; Baccala, A. A.; Rastinehad, A. R.; Merino, M. J.; Shih, J. H.; Wood, B. J.; Pinto, P. A.; Choyke, P. L.
  3. Radiology. 2011, Feb; 258(2): 488-495.
  1. 10.   NKT cells: to suppress or not to suppress, that is the question
  2. Subleski, J. J.; Ortaldo, J. R.
  3. Journal of Leukocyte Biology. 2009 86(4): 751-752.
  1. 11.   Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity
  2. Hu, J. Y.; Li, G. C.; Tong, Y. Q.; Li, Y. H.; Zhou, G. H.; He, X. J.; Xie, P. L.; Wang, J. M.; Sun, Q. B.
  3. International Immunopharmacology. 2005, JUN; 5(6): 971-980.
  1. 12.   Rac1 mediates collapse of microvilli on chemokine-activated T lymphocytes
  2. Nijhara, R.; van Hennik, P. B.; Gignac, M. L.; Kruhlak, M. J.; Hordijk, P. L.; Delon, J.; Shaw, S.
  3. Journal of Immunology. 2004, OCT 15; 173(8): 4985-4993.
  1. 13.   Nitric oxide, a mediator of inflammation, suppresses tumorigenesis
  2. Hussain, S. P.; Trivers, G. E.; Hofseth, L. J.; He, P. J.; Shaikh, I.; Mechanic, L. E.; Doja, S.; Jiang, W. D.; Subleski, J.; Shorts, L.; Haines, D.; Laubach, V. E.; Wiltrout, R. H.; Djurickovic, D.; Harris, C. C.
  3. Cancer Research. 2004, OCT 1; 64(19): 6849-6853.
  1. 14.   Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils
  2. Kamohara, H.; Matsuyama, W.; Shimozato, O.; Abe, K.; Galligan, C.; Hashimoto, S. I.; Matsushima, K.; Yoshimura, T.
  3. Immunology. 2004 111(2): 186-194.
  1. 15.   Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis
  2. Fisher, M.; Kripke, M. L.
  3. Bulletin of The World Health Organization. 2002 80(11): 908-912.
  1. 16.   The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function
  2. Khan, S. G.; Muniz-Medina, V.; Shahlavi, T.; Baker, C. C.; Inui, H.; Ueda, T.; Emmert, S.; Schneider, T. D.; Kraemer, K. H.
  3. Nucleic Acids Research. 2002 30(16): 3624-3631.
  1. 17.   Comparative genome organization of the major histocompatibility complex: lessons from the Felidae
  2. O'Brien, S. J.; Yuhki, N.
  3. Immunological Reviews. 1999 167: 133-144.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel